Neurology medications

Showing 48 of 124 medications in neurology medications (page 1 of 3). Jump to clinical reference & sources below

Filter by condition:
Showing 48 of 124 medications (Page 1 of 3)

Drug Classes & How They Work

  • Guidelines from the American Academy of Neurology (AAN) and the American Headache Society (AHS) organize neurological agents by their receptor, ion-channel, or neuropeptide target (1.1) (2.1) (4.1).
Neurological Subclass Representative Active Ingredients Primary Mechanism of Action Primary Clinical Indications & Notes
Gepants (CGRP receptor antagonists) & CGRP mAbs Rimegepant (Nurtec ODT), ubrogepant (Ubrelvy), atogepant (Qulipta), erenumab (Aimovig), fremanezumab (Ajovy), galcanezumab (Emgality) Blocks calcitonin gene-related peptide (CGRP) receptor or ligand without causing cerebral vasoconstriction Acute migraine treatment (rimegepant, ubrogepant) and episodic/chronic migraine prevention; safe in patients with cardiovascular risk factors (1.1) (2.1)
Serotonin 5-HT1B/1D/1F agonists (triptans & ditans) Sumatriptan (Imitrex), rizatriptan (Maxalt), zolmitriptan (Zomig), eletriptan (Relpax), frovatriptan, almotriptan Cranial vessel vasoconstriction and inhibition of trigeminal pro-inflammatory neuropeptide release Acute abortive treatment of moderate-to-severe migraine attacks; triptans are contraindicated in coronary artery disease or uncontrolled hypertension (1.1) (2.1)
Antiseizure & neuropathic pain modulators Levetiracetam (Keppra), lamotrigine (Lamictal), topiramate (Topamax), carbamazepine (Tegretol), gabapentin (Neurontin), pregabalin (Lyrica), valproic acid SV2A binding, voltage-gated Na+ channel blockade, or alpha-2-delta calcium channel subunit modulation Focal and generalized seizures, trigeminal neuralgia (carbamazepine), migraine prophylaxis (topiramate), and neuropathic pain (gabapentin, pregabalin) (2.1) (3.1)
Dopaminergic Parkinson's & RLS therapies Levodopa/carbidopa (Sinemet), pramipexole (Mirapex), ropinirole (Requip), rasagiline (Azilect), entacapone Central dopamine precursor replenishment, D2/D3 receptor agonism, or MAO-B / COMT enzymatic inhibition Motor symptom control in Parkinson's disease and moderate-to-severe primary restless legs syndrome (2.1) (4.1)
Cholinesterase inhibitors & NMDA antagonists Donepezil (Aricept), rivastigmine (Exelon), galantamine, memantine (Ebixa / Namenda) Reversible acetylcholinesterase inhibition or uncompetitive NMDA glutamate receptor antagonism Symptomatic cognitive and functional management in mild, moderate, and severe Alzheimer's disease (2.1) (4.1)

Neurology medications: Clinical Overview & Scope

Dosage Forms, Release Profiles & Devices

  • Neurological medications utilize specialized delivery routes to address gastroparesis, dysphagia, or fluctuating motor "wearing-off" episodes (1.1) (2.1).
  • During an acute migraine attack, gastric stasis frequently delays the absorption of standard oral tablets; orally disintegrating tablets (ODTs), such as rimegepant (Nurtec ODT), rizatriptan (Maxalt MLT), and zolmitriptan ODT, dissolve on the tongue in seconds without liquid, while intranasal sprays and subcutaneous auto-injectors (sumatriptan, zolmitriptan) bypass the stomach entirely for rapid onset (1.1) (2.1).
  • In epilepsy and Parkinson's disease, extended-release tablets (such as carbamazepine CR/XR, levetiracetam XR, or levodopa/carbidopa CR) smooth plasma concentration peaks and troughs; switching between immediate-release and extended-release anticonvulsants or between different manufacturers of narrow-therapeutic-index antiseizure medications requires close clinical supervision (2.1) (3.1).

Key Safety, Storage & Monitoring Points

  • Neurological medication therapy requires strict adherence to titration schedules and drug-interaction precautions (2.1) (3.1).
  • Antiseizure medications must never be discontinued abruptly, as sudden withdrawal can precipitate breakthrough seizures or life-threatening status epilepticus (2.1) (3.1).
  • Lamotrigine (Lamictal) carries a boxed warning for serious dermatologic reactions, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN); strict adherence to slow starter-dose titration over several weeks (with halved doses if co-administered with valproate) is essential, and carbamazepine requires HLA-B*1502 genetic screening in patients of Asian ancestry prior to initiation (2.1) (3.1).
  • Valproate/divalproex and topiramate carry teratogenic risks (neural tube defects and oral clefts) requiring effective contraception counseling in patients of childbearing potential (2.1) (3.1).
  • In migraine management, triptans are contraindicated in patients with ischemic heart disease, Prinzmetal's angina, cerebrovascular disease, or uncontrolled hypertension, whereas CGRP antagonists (gepants) require dose adjustments or avoidance with strong CYP3A4 inhibitors (such as clarithromycin, itraconazole, or ketoconazole) (1.1) (2.1).

Ordering & Prescription Checklist for U.S. Patients

  • Match your prescription details: Confirm the active ingredient name, exact milligram or microgram strength, release profile, and package quantity on your U.S. prescription (2.1) (4.1).
  • Licensed pharmacist review: Every order undergoes a dosing, strength, and drug-interaction check in under 1 business day, followed by a mandatory pharmacist consultation before dispatch (3.1).
  • Transparent USD pricing and shipping: Room-temperature medications ship for $14.99 USD flat rate and cold-chain medications ship in $29.99 USD insulated coolers via tracked Canada Post and USPS delivery.
  • Need help matching a product or transferring an Rx? Call 1-888-868-1920 (Monday - Friday: 9:00AM - 6:00PM; Saturday - Sunday: Closed) or review our step-by-step ordering guide and prescription requirements.

Frequently Asked Questions

How do CGRP migraine medications like Nurtec ODT, Ubrelvy, and Qulipta differ from triptans?

Triptans (such as sumatriptan and rizatriptan) stimulate serotonin 5-HT1B/1D receptors and constrict blood vessels, making them contraindicated in patients with coronary artery disease, stroke history, or uncontrolled high blood pressure (1.1) (2.1). CGRP receptor antagonists (gepants) block the pain-signaling peptide CGRP directly without constricting blood vessels and do not cause medication-overuse headache.

Why does Lamictal (lamotrigine) require such a slow, multi-week starting schedule?

Starting lamotrigine at a high dose or escalating too quickly significantly increases the risk of serious, potentially life-threatening skin rashes (Stevens-Johnson syndrome) (2.1) (3.1). Following the gradual 5- to 6-week upward titration allows the immune system to adapt safely.

Why should Parkinson medications like Sinemet (levodopa/carbidopa) be timed carefully around high-protein meals?

Dietary amino acids from high-protein foods compete with levodopa for active transport across both the intestinal wall and the blood-brain barrier (2.1) (4.1). Taking levodopa 30 to 60 minutes before meals (unless nausea occurs) helps maintain consistent motor symptom control.

References & Official Clinical Sources

Pharmacological classifications, mechanism comparisons, dosing-form distinctions, and clinical safety notes for neurology medications are compiled from official regulatory prescribing monographs and medical practice guidelines:

Need help finding your medication? Call 1-888-868-1920.

Call 1-888-868-1920Help